Computerised decision support for poorly-controlled type 2 diabetes mellitus in Irish General Practice

Not Applicable

Completed

• Conditions: Poorly controlled type 2 diabetes mellitus (T2DM); Nutritional, Metabolic, Endocrine; Type 2 diabetes mellitus

• Registration Number: ISRCTN69498919
• Lead Sponsor: HRB Centre for Primary Care Research

Brief Summary

2018 protocol in https://www.ncbi.nlm.nih.gov/pubmed/30345068 2020 results in https://pubmed.ncbi.nlm.nih.gov/32051304/ (added 05/03/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-07-26
• Study Completion: 2019-04-30
• Last Update Posted: 15 March 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 134

Inclusion Criteria

GPs will be the target of the intervention and will be unit of randomisation. All GPs who are part of the HRB Clinical Trials Network will be eligible for inclusion.

1. Only patients with poorly controlled T2DM will be targeted by the GP with the DECIDE intervention
2. Patients must have a diagnosis of T2DM
3. They must be aged over 18 years and less than 75, as there is less evidence about treatment intensification in patients aged above 75 years
4. There is no validated cut-off which defines poor control of T2DM for targeted interventions. For the purposes of this study, the trialists have selected HbA1C or BP levels for which there would be consensus on the importance of intervention and treatment and have clinical face validity in terms of intervention. In the DECIDE study only patients with a HbA1c reading of 8.5% (70 mmol/mol) or above and/or a blood pressure reading over 150/95mmHg will be included
5. Not all patients will be suitable for treatment intensification and individual decisions on treatment changes will be made by each patient’s GP.

Exclusion Criteria

1. All GPs will be included
2. Patients are excluded if they do not fulfill the inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HbA1c, a measure of glycaemic control, collected from medical records at baseline and at 6 months follow up

Secondary Outcome Measures

Name	Time	Method
Medications, blood pressure and lipids collected from medical records at baseline and at 6 months follow up